Intriguingly, both of these two analyses point out that Pi3k/Akt signaling is significantly downregulated in the Sema3d high group, which indicates that Sema3d might affect the progression of HCC through Pi3k/Akt signaling (Supplementary Figures S6, S7). The gene discussed is SEMA3D; the disease is hepatocellular carcinoma.